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Background. An improved understanding of the early cell
injury mechanisms is critical for effective therapy of acute renal
failure (ARF).
Methods. We utilized cDNA microarrays to identify renal
genes that are induced very early after renal ischemia in a mouse
model, whose protein products might provide novel informa-
tion regarding the pathogenesis of ARF. The findings were con-
firmed by downstream mRNA and protein expression studies,
as well as knockdown analysis with antisense primers.
Results. The maximally induced gene (21-fold at 3 hours of
reflow) was Zf9, a Kruppel-like transcription factor involved
in the regulation of transforming growth factor-b1 (TGF-b1).
The rapid induction of Zf9 mRNA was confirmed by Northern
analysis (14.5-fold at 3 hours of reflow) and that of Zf9 pro-
tein by Western analysis (10.5-fold at 3 hours of reflow). Zf9
protein was induced in both proximal and distal tubule cells in
a cytoplasmic as well as nuclear distribution. TGF-b1 protein
was also up-regulated in a pattern parallel to that of Zf9. In
cultured human proximal tubule cells, induction of ischemia by
partial adenosine triphosphate (ATP) depletion resulted in a
rapid up-regulation of both Zf9 and of TGF-b1 proteins. Anti-
sense oligonucleotides to Zf9 markedly blunted the induction
of Zf9 and TGF-b1, and significantly inhibited the apoptotic
response to ATP depletion.
Conclusion. Induction of Zf9 and its transactivating factor
TGF-b1 may play a critical and hitherto unrecognized role in
the early apoptotic response to ischemic renal injury.
Acute renal failure (ARF) secondary to ischemic in-
jury remains a common and potentially devastating prob-
lem in clinical nephrology, with a persistently high rate of
mortality despite significant advances in supportive care
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[1–4]. Pioneering studies over several decades have illu-
minated the roles of persistent vasoconstriction, tubular
obstruction, cellular structural and metabolic alterations,
and the inflammatory response in the pathogenesis of
ARF [4–7]. While these studies have suggested successful
therapeutic approaches in animal models, translational
research efforts in humans have yielded disappointing
results [2–4]. The reasons for this may include the mul-
tifaceted response of the kidney to ischemia, and an in-
complete understanding of the molecular pathogenesis
of ARF [4–8]. Recent advances in cellular and molecular
biology of ischemic renal injury have revealed that proxi-
mal tubule cells undergo a complex temporal sequence of
events. These include loss of cell polarity, cell death due
to apoptosis and necrosis, dedifferentiation and prolifer-
ation of viable cells, and reestablishment of the epithelial
phenotype [6, 7]. An improved understanding of the early
cell injury and repair mechanisms is critical for innovative
and effective therapy.
Attempts at unraveling the molecular basis of these
myriad early renal responses have been facilitated by re-
cent advances in functional genomics that have yielded
new tools for genome-wide analysis of complex biologic
processes such as ischemic ARF [8–11]. Utilizing cDNA
microarray methodologies, we have identified a subset of
seven genes whose expression is up-regulated more than
tenfold within the first few hours following ischemic re-
nal injury in a mouse model [11]. Two of these transcripts,
namely cysteine-rich protein 61 (Cyr61) and neutrophil
gelatinase-associated lipocalin (NGAL), have been con-
firmed to be induced by renal ischemia [11–13], but the
behavior of the other five differentially expressed genes
is novel to the ARF literature. In this study, we chose
to further characterize one of these previously unrec-
ognized genes, namely Zf9, a Kruppel-like transcription
factor involved in the regulation of a variety of genes,
including transforming growth factor-b1 (TGF-b1) [14–
17]. Zf9 mRNA is known to be expressed in the embry-
onic kidney [17]. However, the expression and function
of Zf9 mRNA or protein in the mature kidney remain
unknown.
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In this study, we have demonstrated the rapid and dra-
matic induction of both Zf9 and TGF-b1 in animal models
and cultured cells. Our results indicate that these proteins
may play a critical and hitherto unrecognized role in the
early apoptotic response to ischemic renal injury.
METHODS
Mouse models of renal ischemia/reperfusion (I/R) injury
We utilized well-established murine models in which
the structural and functional consequences of brief peri-
ods of renal ischemia have been previously documented
[11, 12, 18]. Briefly, male Swiss-Webster mice (Taconic
Farms, Germantown, NY, USA) weighing 25 to 30 g were
housed with 12:12 hour light:dark cycle and were allowed
free access to food and water. The animals were anes-
thetized with sodium pentobarbital (50 mg/kg intraperi-
toneally) and placed on a warming table to maintain a
rectal temperature of 37◦C. Both renal pedicles were oc-
cluded with a nontraumatic vascular clamp for 30 min-
utes, during which time the kidney was kept warm and
moist. The clamps were then removed, the kidney ob-
served for return of blood flow, and the incision sutured.
The mice were allowed to recover in a warmed cage. Af-
ter various reperfusion periods, the animals were reanes-
thetized, sacrificed, the kidneys’ perfusion fixed in situ
with 4% paraformaldehyde in phosphate-buffered saline
(PBS), and both kidneys harvested. One half of each
kidney was snap-frozen in liquid nitrogen and stored at
−70◦C until further processing. The other half of each kid-
ney was embedded in 22-oxacalcitriol (OCT) compound
(Tissue-Tek, Sakura, Torrance, CA, USA) and frozen sec-
tions (4 lm) obtained for immunohistochemistry.
Northern analysis
An expressed sequence tag (EST) clone (GenBank
#AA067146) containing the full-length insert encoding
mouse Zf9 was purchased from ATCC (Manassas,
VA, USA). Following sequence verification, the insert
was excised with EcoRI and XhoI, purified from a
low-melting agarose TAE gel, and labeled with 32P.
Total cellular RNA was extracted from snap-frozen
kidney tissue using the RNeasy Mini Kit (Qiagen,
Valencia, CA, USA). Total cellular RNA (30 mg/lane)
was size fractionated on a 1.2% agarose-formaldehyde
gel and transferred to nylon membranes by capillary
transfer using 10× sodium chloride-sodium phosphate-
ethylenediaminetetraacetic acid (EDTA) buffer.
Membranes were cross-linked by ultraviolet light,
hybridized to the 32P-labeled Zf9 cDNA insert, washed,
and exposed to Phosphor-Imager screens at room
temperature for 24 hours.
Western analysis
Kidney tissue samples were homogenized in ice-cold
isolation solution (250 mmol/L sucrose, 10 mmol/L tri-
ethaolamine, and 1× Complete protease inhibitor, pH
7.5), using a Polytron homogenizer. The homogenate was
centrifuged at low speed (1,000 × g) for 10 minutes at
4◦C to remove cellular debris. Protein concentrations of
the supernates were determined by the Bradford Assay
(Bio-Rad, Hercules, CA, USA). Equal amounts of to-
tal protein were loaded in each lane and subjected to
sodium dodecyl sulfate-polyacrylamide gel electrophore-
sis (SDS-PAGE). Immunodetection of transferred pro-
teins was achieved using enhanced chemiluminescence
(ECL) (Amersham, Arlington Heights, IL, USA).
Immunohistochemistry
For Zf9 detection, frozen kidney sections were perme-
abilized with 0.2% Triton X-100 in PBS for 10 minutes,
blocked with goat serum for 1 hour, and incubated with
primary antibodies for 1 hour. Slides were then exposed
for 60 minutes to biotinylated secondary antibody, incu-
bated for 30 minutes in horseradish peroxidase (HRP)-
streptavidin complex, developed for 5 minutes with HRP
substrate mixture (ImmunoCruz Staining Systems, Santa
Cruz Biotechnology, Santa Cruz, CA, USA), counter-
stained with hematoxylin, and visualized with a micro-
scope (Zeiss Axiophot; Carl Zeiss, Inc., Thornwood, NY,
USA). In order to better visualize nuclear localization, a
separate set of slides were prepared without hematoxylin
counterstaining.
Cell culture
Human renal proximal tubular epithelial cells
(RPTECs) were obtained from Clonetics (San Diego,
CA, USA). Cells were grown in renal epithelial cell basal
medium supplemented with REGM complex [0.5 lL/mL
hydrocortisone, 10 pg/mL human epidermal growth fac-
tor (hEGF), 0.5 lg/mL epinephrine, 6.5 pg/mL triiodothy-
ronine, 10 lg/mL transferrin, 5 lg/mL insulin, 1 lg/mL
gentamicin sulfate, and 2% fetal bovine serum (FBS)], as
recommended by the manufacturer.
Mild adenosine triphosphate (ATP) depletion of cultured
cells
We modified previously described protocols of in vitro
ischemia by ATP depletion with inhibitors of oxida-
tive phosphorylation [19, 20]. On the second day post-
confluence, RPTEC cells were incubated with 1 lm
antimycin A (Sigma Chemical Co., St. Louis, MO, USA)
for varying periods of time up to 12 hours. We have previ-
ously shown that this results in mild partial ATP depletion
in cultured renal epithelial cells such as Madin-Darby ca-
nine kidney (MDCK) [19], 786-O [20], and RPTECs [12].
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ATP levels were monitored using a luciferase-based assay
kit (Sigma Chemical Co.), and expressed as a percentage
of control values. Cells were harvested at various time
points of ATP depletion and subjected to Western anal-
ysis.
Antisense oligonucleotides to Zf9
Phosphorothioated antisense and sense 23-mer
oligonucleotides directed to the translation initiation
site of human Zf9 were synthesized as follows: antisense,
5′-CACATCCATGTCGGGTTGGAAAA-3′; sense,
5′-ACTGTCTTTTCCAACCCGACATG-3′. RPTEC
cells were grown to 80% confluence and washed with
Opti-MEM (Life Technologies, Gaithersburg, MD,
USA). Oligonucleotides (final concentration 10 lmol/L)
were incubated in 10 mg/mL LipofectAMINE reagent
(Life Technologies) in Opti-MEM for 30 minutes at
room temperature and then applied to the washed cells
for 5 hours at 37◦C [20]. The oligonucleotide-containing
medium was removed, the cells washed and incubated in
standard growth medium for 24 hours, and subjected to
partial ATP depletion by incubating with 1 lm antimycin
A (Sigma Chemical Co.) for varying periods of time up
to 12 hours. Cells were harvested at various time points
of ATP depletion, and analyzed for Zf9 and TGF-b1
protein expression by Western analysis, and apoptosis
assays as detailed below.
Apoptosis assays
RPTECs were subjected to the DNA laddering as-
say for detection of apoptosis as previously described
[19]. Briefly, cells were resuspended in lysis buffer (1%
SDS, 25 mmol/L EDTA, and 1 mg/mL proteinase K,
pH 8) at 50◦C overnight, digested with ribonuclease A
(10 mg/mL), and the chromosomal DNA extracted and
analyzed by agarose gel electrophoresis. In order to
confirm and quantify apoptosis, we performed the ter-
minal deoxynucleotidedyl transferase (TdT)-mediated
deoxyuridine triphosphate (dUTP) nick-end labeling
(TUNEL) assay (ApoAlert Assay Kit) (Clontech) as
previously described [19]. Briefly, cells grown on cover
slips were fixed with 4% formaldehyde for 30 minutes at
4◦C, permeabilized with 0.2% Triton X-100 for 15 min-
utes at 4◦C, incubated with a mixture of nucleotides and
TdT enzyme for 60 minutes at 37◦C in a dark humidi-
fied chamber, the reaction terminated with 2× standard
sodium citrate (SSC), and the coverslips mounted on glass
slides. Apoptotic nuclei were detected by visualization
with a fluorescent microscope. Slides were examined in a
blinded fashion, and apoptosis was quantified by count-
ing the number of TUNEL-positive nuclei per 100 cells
counted in an average of five high power (40×) fields in
each section. Only cells that displayed the characteristic
morphology of apoptosis, including nuclear fragmenta-
tion, nuclear condensation, and intensely fluorescent nu-
clei by TUNEL assay, were counted as apoptotic. Merely
TUNEL-positive cells, in the absence of morphologic cri-
teria, were not considered apoptotic.
Other materials and methods
All chemicals were purchased from Sigma Chemical
Co. unless otherwise specified. The polyclonal antibody
to Zf9 (Santa Cruz Biotechnology) was used at 1:500 di-
lution, and polyclonal antibody to TGF-b1 (noncrossre-
active with other TGF-b family members) (Santa Cruz
Biotechnology) was used at 1:1000 dilution. Monoclonal
antibody to a-tubulin (Sigma Chemical Co.) was used
at 1:10,000 dilution for confirmation of equal protein
loading.
RESULTS
Characterization of the mouse model of ischemic renal
injury
We utilized a well-established mouse model of early
renal I/R injury characterized by the presence of tubule
cell apoptosis and necrosis [11, 12, 18]. The character-
istic functional derangements and histopathologic fea-
tures of ischemic injury were readily evident in the
24-hour reperfusion samples. These included an elevation
in serum creatinine (2.5 ± 0.6 mg/dL in the 24-hour re-
flow animals versus 0.6 ± 0.3 mg/dL in the control group)
(P < 0.05), loss of brush border membranes, tubular di-
latation, flattened tubular epithelium, luminal debris, and
an interstitial infiltrate [11, 12, 18]. Also evident were
tubule epithelial cells that displayed the characteristic
morphology of apoptotic nuclei as previously described
[11, 12, 18], consisting of condensed, fragmented, and in-
tensely staining nuclei. We have previously published the
results of microarray analysis of RNA samples obtained
from ischemic mouse kidneys after various periods of re-
flow [11]. One of the maximally induced genes was iden-
tified as Zf9, a Kruppel-like transcription factor involved
in the regulation of a variety of genes.
Induction of mouse kidney Zf9 mRNA after ischemia
By Northern analysis with a cDNA probe for mouse
Zf9, a single message of 4.5 kb was detected in control
kidneys (Fig. 1), as previously shown for other tissues [16,
21, 22]. Examination of mRNA obtained at various pe-
riods of reflow following kidney ischemia confirmed the
marked induction of Zf9 as suggested by our previous
microarray results. By densitometry, the fold induction
of Zf9 was 14.5 ± 3 at 3 hours, 10.5 ± 3 at 12 hours, and
2.5 ± 1 at 24 hours of reflow. These results were com-
parable to those obtained by microarray analysis, which
revealed a fold induction of Zf9 of 21.2 ± 2 at 3 hours,
12.4 ± 2 at 12 hours, and 3.2 ± 1 at 24 hours of reflow, as
shown in Figure 1.
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Fig. 1. Induction of Zf9 mRNA after kidney ischemia. (A) Represen-
tative Northern blot with a probe for mouse Zf9, using RNA extracted
from kidneys of control (Con) mice or after various reperfusion periods
as shown (hours). (B) Quantitation of Zf9 mRNA expression (means
± SD) at various time points by microarray (solid line) versus North-
ern analysis (dotted line) from four separate experiments at each time
point. Kidney Zf9 mRNA was markedly induced very early following
ischemic injury.
Induction of mouse kidney Zf9 and TGF-b1 protein after
ischemia
It was next of interest to determine whether the postis-
chemic expression of Zf9 protein in the kidney parallels
that of the mRNA. By Western analysis, Zf9 in control
kidney lysates was just detectable as two immunoreactive
peptides of 42 and 46 kD, as shown in Figure 2, similar
to its expression in cultured cells [16, 23]. Examination
of lysates obtained at various periods of reflow follow-
ing kidney ischemia confirmed the marked induction of
Zf9 protein (both the 42 and the 46 kD peptides), as sug-
gested by our previous mRNA expression analysis. By
densitometry, the fold increase in Zf9 protein expression
was 10.5 ± 2 at 3 hours, 9.5 ± 3 at 12 hours, 6.5 ± 1 at
24 hours, and 4.5 ± 1 at 48 hours of reflow.
Using immunohistochemical techniques, we next
demonstrated that Zf9 protein was barely detectable in
control mouse kidneys, but was markedly up-regulated
in both proximal and distal nephron segments following
ischemia (Fig. 3). This was evident within 3 hours, accen-
tuated at later time points, and persistent at 48 hours of
reflow. Within these epithelial cells, Zf9 was expressed in
a diffuse cytoplasmic pattern as well as in the nucleus, con-
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Fig. 2. Induction of Zf9 and transforming growth factor-b1 (TGF-b1)
protein after kidney ischemia. Representative Western blots with whole
kidney lysates obtained from control (Con) mice or after 30 minutes of
ischemia and reperfusion periods as shown (hours), probed with anti-
bodies to Zf9, TGF-b1, and tubulin (Tub) (to demonstrate equal protein
loading). Kidney Zf9 and TGF-b1 protein were markedly and coordi-
nately induced very early following ischemic injury. Figure represents
four independent experiments.
sistent with its role as a transcription factor. The glomeruli
and interstitium were essentially devoid of Zf9 staining.
Since Zf9 may be involved in the regulation of a va-
riety of genes, including TGF-b1 [14–17], we next ex-
amined the expression of TGF-b1 protein. By Western
analysis, TGF-b1 in control kidney lysates was just de-
tectable as a 15 kD, as shown in Figure 2. Examination
of lysates obtained at various periods of reflow follow-
ing kidney ischemia confirmed the marked induction of
TGF-b1 protein, in a pattern parallel to that of Zf9.
Induction of Zf9 and TGF-b1 protein in RPTECs by ATP
depletion
We next examined the expression of Zf9 and TGF-b1
protein in cultured human RPTECs subjected to mild
ischemic injury by partial ATP depletion. Incubation of
RPTECs in 1 lm antimycin resulted in a mild partial ATP
depletion to about 83 ± 3% of control within 1 hour,
with a more gradual decrease to about 75 ± 3% of con-
trol by 6 hours (mean ± SD from four experiments). Zf9
protein was just detectable in resting cells as a predomi-
nantly 46 kD immunoreactive peptide (Fig. 4), as previ-
ously described in some other cell types [14]. Following
partial ATP depletion, a rapid and duration-dependent
induction of Zf9 protein was evident, as shown in
Figure 4. Similarly, TGF-b1 protein was detectable as a
15 kD species in control cells, and there was a rapid and
parallel increase in TGF-b1 protein expression following
ATP depletion. Thus, the responses of Zf9 and TGF-b1
protein were similar in an animal model and in a cell cul-
ture model of ischemic kidney injury.
Inhibition of the Zf9 response to ATP depletion by
antisense primers
In order to explore the functional consequences of
Zf9 induction, we designed antisense oligonucleotide
experiments to downregulate the expression of Zf9.
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Fig. 3. Immunolocalization of Zf9 protein af-
ter kidney ischemia. Representative immuno-
histochemistry results on frozen sections of
mouse kidneys obtained from control (Con)
animals or after 30 minutes of ischemia and
reperfusion periods as shown (hours), probed
with antibody to Zf9. Top four panels show
slides counterstained with hematoxylin, show-
ing the cytoplasmic distribution in proximal
and distal tubule cells. Bottom two panels
show results with no counterstain, revealing
the nuclear localization. Results were repro-
ducible in four experiments.
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Fig. 4. Induction of Zf9 and transforming growth factor-b1 (TGF-b1)
protein in renal proximal tubular epithelial cells (RPTECs) by adeno-
sine triphosphate (ATP) depletion. Representative Western blots with
samples obtained from control (Con) RPTECs or after partial ATP de-
pletion periods as shown (hours), probed with antibodies to Zf9, TGF-
b , and tubulin (Tub) (to demonstrate equal protein loading). RPTECs
Zf9 and TGF-b1 protein were markedly and coordinately induced very
early following ATP depletion. Figure represents four independent ex-
periments.
Incubation of RPTECs with a phosphorothioated anti-
sense primer to Zf9 dramatically blunted the response of
Zf9 protein to ATP depletion, as shown in Figure 5. While
cells exposed to sense Zf9 primers exhibited a rapid and
duration-dependent induction of Zf9 protein following
ATP depletion, the expression of Zf9 in cells incubated
with antisense Zf9 primers remained largely unaltered.
Similarly, whereas cells incubated with sense Zf9 primers
displayed an induction of TGF-b1 protein in a parallel
fashion to Zf9, the antisense Zf9 primers essentially abro-
gated this TGF-b1 response to ATP depletion. These re-
sults suggest that the up-regulation of TGF-b1 protein in
RPTECs following ATP depletion is largely consequen-
tial to transcriptional activation by Zf9.
Since recent studies have suggested an emerging role
for TGF-b1 in renal cell apoptosis [24, 25], it was
next of importance to examine the apoptotic response
of RPTECs to partial ATP depletion with concurrent
TGF-b1 inhibition. Cells incubated with sense Zf9
primers displayed significant apoptosis following 12 hours
of partial ATP depletion, as shown in Figure 6. This was
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Fig. 5. Inhibition of renal proximal tubular
epithelial cells (RPTECs) Zf9 and transform-
ing growth factor-b1 (TGF-b1) by antisense
Zf9 primers. Representative Western blots
with samples obtained from control (Con)
RPTECs or after partial adenosine triphos-
phate (ATP) depletion periods as shown
(hours), in the presence of sense or antisense
Zf9 oligonucleotides, probed with antibodies
to Zf9, TGF-b1, and tubulin (Tub) (to demon-
strate equal protein loading). The induction
of RPTECs Zf9 and TGF-b1 was markedly
suppressed by antisense Zf9 primer. Results
were reproducible in four independent exper-
iments.
documented by the demonstration of DNA laddering,
and quantified by TUNEL assay. In contrast, cells in-
cubated with antisense Zf9 primers displayed a signifi-
cant blunting of the apoptotic response to ATP depletion.
Whereas the apoptosis rate following ATP depletion in
cells transfected with sense Zf9 primer was 34 ± 4 cells per
100 cells examined, incubation with antisense Zf9 primer
dramatically reduced the apoptosis rate to 18 ± 4 cells
per 100 cells counted. However, despite Zf9 and TGF-b1
inhibition, this rate remained significantly above control
nonischemic cells, which displayed a basal apoptosis rate
of only 3 ± 1 cells per 100 cells examined.
DISCUSSION
The Kruppel transcription factor was first identified
in Drosophila as a segmentation gene [26]. Additional
Kruppel-like zinc finger transcription factors now com-
prise a conserved family of DNA binding proteins that
are important in developmental regulation [26–28]. The
Zf9 gene was initially identified as a cDNA encoding for a
core promoter binding protein [21], and was subsequently
shown to represent a transcription factor with a typical
zinc finger DNA binding domain and a unique N-terminal
domain rich in serine-proline clusters with high homol-
ogy to the Kruppel-like family of transcription factors
[14–16]. The Zf9 mRNA is differentially expressed in ma-
ture tissues, with enrichment in the placenta, lung, and
pancreas and only minimal expression in the kidney [21,
22]. The Zf9 message is abundantly expressed in the em-
bryonic kidney, predominantly in the ureteric bud and its
branches, suggesting a role in the development of the col-
lecting system [17]. However, the expression and function
of Zf9 in the mature kidney have remained unknown. In
this manuscript, we report that Zf9 mRNA is expressed
as a single 4.5 kb message in control mouse kidneys, as
previously shown for other tissues [16, 21, 22]. This mes-
sage is translated into two polypeptide products of 42 and
46 kD. A similar pattern of expression of Zf9 as 42 and
46 kD species has been described in cultured endothelial
cells [16] and BALB/c 3T3 cells [23]. The molecular basis
and significance of these two translation products from a
single message remain to be explored. In control mouse
kidneys, Zf9 protein is expressed at a low level in both
proximal and distal tubule cells, in a diffuse cytoplasmic
distribution. No glomerular or interstitial staining was
detected.
Zf9 is one of the maximally induced genes in the kidney
in the early phases of I/R injury. This was initially detected
by microarray analysis [11], and confirmed in this study
by Northern analysis. The translated protein products fol-
lowed the same pattern, being induced about tenfold at
the 3- and 12-hour reperfusion periods, in a nuclear as
well as cytoplasmic distribution in tubule epithelial cells.
A similar rapid induction of Zf9 has been reported in
hepatic stellate cells from animals following acute carbon
tetrachloride injury [14]. The localization and temporal
pattern of Zf9 expression is highly suggestive of a role
in the immediate-early response of kidney tubule cells to
ischemic injury, which includes loss of cell polarity and
cell death due to apoptosis and/or necrosis [6, 7, 29]. In
particular, several recent studies have documented that
brief periods of ischemia in animal models leads to apop-
tosis of tubule epithelial cells within 3 to 12 hours of the
injury [29–35], at the same time that Zf9 is maximally in-
duced. The occurrence of early-onset apoptosis has now
been confirmed in biopsy samples from transplanted ca-
daveric kidneys, which constitutes a human model for
renal I/R injury [36–38]. Others [30] and we [29] have hy-
pothesized that down-regulation of apoptosis may offer
a therapeutic approach to I/R injury in both the native
and the transplanted kidney. Considerable efforts have
consequently been directed toward identification of the
intracellular pathways involved in the ischemia-induced
tubule cell apoptosis. It was therefore of interest to ex-
amine downstream targets of Zf9 that may play a role in
renal cell apoptosis.
There is accumulating evidence indicating that TGF-
b1 is one of the primary targets of Zf9, and that tran-
scriptional activation of TGF-b1 by Zf9 may play a
critical role in the response to injury, at least in vascu-
lar endothelial cells [14–16, 39]. In the kidney, TGF-b1
has emerged as a pleiotropic regulator of cell prolifer-
ation, differentiation, and apoptosis, depending on the
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Fig. 6. Inhibition of renal proximal tubular epithelial cell (RPTEC) apoptosis by antisense Zf9 primers. Results of DNA laddering (top left)
and erminal deoxynucleotidedyl transferase (TdT)-mediated deoxyuridine triphosphate (dUTP) nick-end labeling (TUNEL) (top right) apoptosis
assays with samples obtained from control (Con) RPTECs or after partial adenosine triphosphate (ATP) depletion for 12 hours in the presence
of sense or antisense Zf9 oligonucleotides. Bottom panels show representative images of the TUNEL studies. The expected induction of RPTEC
apoptosis by ATP depletion was significantly but not completely suppressed by antisense Zf9 primers. ∗P < 0.05 versus control; #P < 0.05 versus
mock transfections (cells incubated in all transfection materials except the primers). Values are means ± SD from four experiments.
physiological context [24]. Elegant recent studies have
demonstrated that TGF-b1 dramatically accelerates
renal tubular epithelial cell apoptosis initiated by
staurosporine, by a Smad-independent, p38 mitogen-
activated protein (MAP) kinase-dependent mechanism
[40]. Relatively little is known about the TGF-b1 re-
sponse in acute ischemic renal injury, a well estab-
lished proapoptotic stimulus. Previous work by others
has shown that TGF-b1 mRNA and protein are induced
in tubule cells within 12 hours of ischemic injury in a rat
model [41]. Our previous microarray analysis has demon-
strated that TGF-b1 mRNA is markedly up-regulated
within 3 hours of I/R injury in an established mouse
model [11]. In this manuscript, we have demonstrated
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a rapid and dramatic induction of TGF-b1 protein, in a
temporal pattern similar to that of Zf9, in mouse mod-
els as well as in cultured human proximal tubule cells.
Inhibition of Zf9 transcription using antisense oligonu-
cleotide technology prevented the up-regulation of both
Zf9 and TGF-b1, indicating that the induction of TGF-b1
was indeed secondary to transactivation by Zf9. Impor-
tantly, this also resulted in a significant blunting of the
apoptotic response to ATP depletion in these cultured
cells (by about 50%). These results indicate that TGF-b1
plays an important role in the early renal tubule cell
apoptosis initiated by ATP depletion. However, despite
Zf9 and TGF-b1 inhibition, the apoptosis rate remained
significantly above control nonischemic cells, indicating
that TGF-b1–independent mechanisms should also be in-
voked in the apoptosis induced by ATP depletion.
It is interesting to note that both Zf9 and TGF-b1 re-
main significantly induced even at later time points (up
to 48 hours in this study) following ischemic renal in-
jury. Previous reports have demonstrated that TGF-b1
remains up-regulated in renal tubule cells for up to 14
days after ischemia [41]. These findings have lead to the
hypothesis that renal TGF-b1 may also serve to promote
tissue regeneration following acute injury. Later peaks
of Zf9 expression have also been demonstrated in hep-
atic stellate cells following injury [14]. Collectively, these
findings raise the possibility that Zf9 and its target fac-
tors such as TGF-b1 may have functionally distinct roles
at different points along the temporal sequence of cellular
events following ischemic injury. During the immediate-
early phase, Zf9 and its transactivated factors may be
responsible, at least in part, for the tubule cell death and
ensuing renal dysfunction. In the later phases, the same
response may be important for the processes of tubule
cell proliferation, differentiation, and reestablishment of
a polarized epithelial lining [29]. Additional support for
these concepts may be derived from recent findings indi-
cating that Zf9 induces the transcription of HSP47, a well-
documented molecular chaperone that plays a key role
in the response to stress [42]. The induction of Zf9 both
during nephrogenesis [16] as well as following ischemic
injury in the mature kidney (this manuscript) follows a
pattern that is now becoming increasingly evident for a
number of genes [12, 13, 29]. These findings lend further
confirmation to the notion that renal regeneration reca-
pitulates development, and that the kidney possesses a
remarkable intrinsic ability to repair itself following is-
chemic damage [29, 43].
CONCLUSION
This study demonstrates the rapid and dramatic
ischemia-induced up-regulation of both Zf9 and TGF-
b1 in animal models and cultured cells. Our results indi-
cate that these proteins may play a critical and hitherto
unrecognized role in the early apoptotic response to is-
chemic renal injury. It will be important in future studies
to determine whether interference with this immediate-
early response can alter the functional consequences of
ischemic injury in animal models by modifying the degree
of apoptotic tubule cell death. Such findings may provide
novel tools to combat the early phases of ischemic ARF,
a common human condition still associated with a dis-
mal prognosis where innovative therapies are desperately
needed.
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